You have full text access to this OnlineOpen article

Cytokines and schizophrenia: Microglia hypothesis of schizophrenia

Akira Monji md, phd^*,
Takahiro Kato md, phd,
Shigenobu Kanba md, phd

Article first published online: 13 APR 2009

DOI: 10.1111/j.1440-1819.2009.01945.x

Issue

Psychiatry and Clinical Neurosciences

Volume 63, Issue 3, pages 257–265, June 2009

Additional Information

How to Cite

Monji, A., Kato, T. and Kanba, S. (2009), Cytokines and schizophrenia: Microglia hypothesis of schizophrenia. Psychiatry and Clinical Neurosciences, 63: 257–265. doi: 10.1111/j.1440-1819.2009.01945.x

Author Information

Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

^* *Akira Monji, MD, PhD, Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Maidashi 3-1-1, Higashi-ku, Fukuoka 812-8582, Japan. Email: amonji@hf.rim.or.jp

Publication History

Issue published online: 14 MAY 2009
Article first published online: 13 APR 2009
Accepted 27 January 2009.

ARTICLE TOOLS

View Full Article (HTML) Get PDF (193K)

REFERENCES

1
Koyama A, Ito H, Nakanishi M, Sawamura K, Higuchi T. Addition of antipsychotics to medication regimens during schizophrenic inpatient care. Psychiatry Clin. Neurosci. 2008; 62: 56–64.
Direct Link:
2
Chien IC, Hsu JH, Bih SH et al. Prevalence, correlates, and disease patterns of antipsychotic use in Taiwan. Psychiatry Clin. Neurosci. 2008; 62: 677–684.
Direct Link:
3
Ozbey U, Tug E, Kara M, Namli M. The value of interleukin-12B (p40) gene promoter polymorphism in patients with schizophrenia in a region of East Turkey. Psychiatry Clin. Neurosci. 2008; 62: 307–312.
Direct Link:
4
Bessis A, Bechade C, Bernard D, Roumier A. Microglial control of neuronal death and synaptic properties. Glia 2007; 55: 233–238.
Direct Link:
5
Ogawa K, Yamada T, Tsujioka Y et al. Localization of a novel type trypsin-like serine protease, neurosin, in brain tissues of Alzheimer's disease and Parkinson's disease. Psychiatry Clin. Neurosci. 2000; 54: 419–426.
Direct Link:
6
Ishizuka K, Kimura T, Igata R, Katsuragi S, Takamatsu J, Miyakawa T. Identification of monocyte chemoattractant protein-1 in senile plaques and reactive microglia of Alzheimer's disease. Psychiatry Clin. Neurosci. 1997; 51: 135–138.
Direct Link:
7
Hanisch U. Microglia as a source and target of cytokines. Glia 2002; 40: 140–155.
Direct Link:
8
Arion D, Unger T, Lewis DA, Levitt P, Mirnics K. Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Biol. Psychiatry 2007; 62: 711–721.
9
Drzyzga L, Obuchowicz E, Marcinowska A, Herman ZS. Cytokines in schizophrenia and the effects of antipsychotic drugs. Brain Behav. Immun. 2006; 20: 532–545.
10
Narayan S, Tang B, Head SR et al. Molecular profiles of schizophrenia in the CNS at different stages of illness. Brain Res. 2008; 1239: 235–248.
11
Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, Kouassi E. Inflammatory cytokine alterations in schizophrenia: A systematic quantitative review. Biol. Psychiatry 2008; 63: 801–808.
12
Sperner-Unterweger B. Immunological aetiology of major psychiatric disorders: Evidence and therapeutic implications. Drugs 2005; 65: 1493–1520.
13
Lin A, Kenis G, Bignotti S et al. The inflammatory response system in treatment-resistant schizophrenia: Increased serum interleukin-6. Schizophr. Res. 1998; 32: 9–15.
14
Zhang XY, Zhou DF, Cao LY, Zhang PY, Wu GY, Shen YC. Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: Relationship to outcome in schizophrenia. J. Clin. Psychiatry 2004; 65: 940–947.
15
Akhondzadeh S, Tabatabaee M, Amini H, Ahmadi Abhari SA, Abbasi SH, Behnam B. Celecoxib as adjunctive therapy in schizophrenia: A double-blind, randomized and placebo-controlled trial. Schizophr. Res. 2007; 90: 179–185.
16
Muller N, Riedel M, Schwarz MJ, Engel RR. Clinical effects of COX-2 inhibitors on cognition in schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 2005; 255: 149–151.
17
Schmitt A, Bertsch T, Henning U et al. Increased serum S100B in elderly, chronic schizophrenic patients: Negative correlation with deficit symptoms. Schizophr. Res. 2005; 80: 305–313.
18
Ashdown H, Dumont Y, Ng M, Poole S, Boksa P, Luheshi GN. The role of cytokines in mediating effects of prenatal infection on the fetus: Implications for schizophrenia. Mol. Psychiatry 2006; 11: 47–55.
19
Nawa H, Takei N. Recent progress in animal modeling of immune inflammatory processes in schizophrenia: Implication of specific cytokines. Neurosci. Res. 2006; 56: 2–13.
20
Nurun BN, Tanaka T, Kamino K et al. Toll-like receptor 3 mediated hyperphosphorylation of tau in human SH-SY5Y neuroblastoma cells. Psychiatry Clin. Neurosci. 2006; 60: S27–S33.
Direct Link:
21
Block ML, Hong JS. Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism. Prog. Neurobiol. 2005; 76: 77–98.
22
Lieberman JA. Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective. Biol. Psychiatry 1999; 46: 729–739.
23
Perez-Neri I, Ramirez-Bermudez J, Montes S, Rios C. Possible mechanisms of neurodegeneration in schizophrenia. Neurochem. Res. 2006; 31: 1279–1294.
24
Nakki R, Koistinaho J, Sharp FR, Sagar SM. Cerebellar toxicity of phencyclidine. J. Neurosci. 1995; 15: 2097–2108.
25
Nakki R, Nickolenko J, Chang J, Sagar SM, Sharp FR. Haloperidol prevents ketamine- and phencyclidine-induced HSP70 protein expression but not microglial activation. Exp. Neurol. 1996; 137: 234–241.
26
Bayer TA, Buslei R, Havas L, Falkai P. Evidence for activation of microglia in patients with psychiatric illnesses. Neurosci. Lett. 1999; 271: 126–128.
27
Radewicz K, Garey LJ, Gentleman SM, Reynolds R. Increase in HLA-DR immunoreactive microglia in frontal and temporal cortex of chronic schizophrenics. J. Neuropathol. Exp. Neurol. 2000; 59: 137–150.
28
Steiner J, Mawrin C, Ziegeler A et al. Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization. Acta Neuropathol. 2006; 112: 305–316.
29
Steiner J, Bielau H, Brisch R et al. Immunological aspects in the neurobiology of suicide: Elevated microglial density in schizophrenia and depression is associated with suicide. J. Psychiatr. Res. 2008; 42: 151–157.
30
Cagnin A, Kassiou M, Meikle SR, Banati RB. In vivo evidence for microglial activation in neurodegenerative dementia. Acta Neurol. Scand. Suppl. 2006; 185: 107–114.
Direct Link:
31
Berckel BN, Bossong MG, Boellaard R et al. Microglia activation in recent-onset schizophrenia: A quantitative (R)-[11C]PK11195 positron emission tomography study. Biol. Psychiatry 2008; 64: 820–822.
32
Warner-Schmidt JL, Duman RS. Hippocampal neurogenesis: Opposing effects of stress and antidepressant treatment. Hippocampus 2006; 16: 239–249.
Direct Link:
33
Reif A, Fritzen S, Finger M et al. Neural stem cell proliferation is decreased in schizophrenia, but not in depression. Mol. Psychiatry 2006; 11: 514–522.
34
Liu J, Suzuki T, Seki T, Namba T, Tanimura A, Arai H. Effects of repeated phencyclidine administration on adult hippocampal neurogenesis in the rat. Synapse 2006; 60: 56–68.
Direct Link:
35
Maeda K, Sugino H, Hirose T et al. Clozapine prevents a decrease in neurogenesis in mice repeatedly treated with phencyclidine. J. Pharmacol. Sci. 2007; 103: 299–308.
36
Pickard BS, Pieper AA, Porteous DJ, Blackwood DH, Muir WJ. The NPAS3 gene: Emerging evidence for a role in psychiatric illness. Ann. Med. 2006; 38: 439–448.
37
Pieper AA, Wu X, Han TW et al. The neuronal PAS domain protein 3 transcription factor controls FGF-mediated adult hippocampal neurogenesis in mice. Proc. Natl Acad. Sci. USA 2005; 102: 14052–14057.
38
Duan X, Chang JH, Ge S et al. Disrupted-In-Schizophrenia 1 regulates integration of newly generated neurons in the adult brain. Cell 2007; 130: 1146–1158.
39
Wakade CG, Mahadik SP, Waller JL, Chiu FC. Atypical neuroleptics stimulate neurogenesis in adult rat brain. J. Neurosci. Res. 2002; 69: 72–79.
Direct Link:
40
Kodama M, Fujioka T, Duman RS. Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat. Biol. Psychiatry 2004; 56: 570–580.
41
Monje ML, Toda H, Palmer TD. Inflammatory blockade restores adult hippocampal neurogenesis. Science 2003; 302: 1760–1765.
42
Ekdahl CT, Claasen JH, Bonde S, Kokaia Z, Lindvall O. Inflammation is detrimental for neurogenesis in adult brain. Proc. Natl Acad. Sci. USA 2003; 100: 13632–13637.
43
Cacci E, Claasen JH, Kokaia Z. Microglia-derived tumor necrosis factor-alpha exaggerates death of newborn hippocampal progenitor cells in vitro. J. Neurosci. Res. 2005; 80: 789–797.
Direct Link:
44
Iosif RE, Ekdahl CT, Ahlenius H et al. Tumor necrosis factor receptor 1 is a negative regulator of progenitor proliferation in adult hippocampal neurogenesis. J. Neurosci. 2006; 26: 9703–9712.
45
Kaneko N, Kudo K, Mabuchi T et al. Suppression of cell proliferation by interferon-alpha through interleukin-1 production in adult rat dentate gyrus. Neuropsychopharmacology 2006; 31: 2619–2626.
46
Davis KL, Stewart DG, Friedman JI et al. White matter changes in schizophrenia: Evidence for myelin-related dysfunction. Arch. Gen. Psychiatry 2003; 60: 443–456.
47
Kumra S, Ashtari M, Cervellione KL et al. White matter abnormalities in early-onset schizophrenia: A voxel-based diffusion tensor imaging study. J. Am. Acad. Child Adolesc. Psychiatry 2005; 44: 934–941.
48
Salisbury DF, Kuroki N, Kasai K, Shenton ME, McCarley RW. Progressive and interrelated functional and structural evidence of post-onset brain reduction in schizophrenia. Arch. Gen. Psychiatry 2007; 64: 521–529.
49
Hulshoff Pol HE, Kahn RS. What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia. Schizophr. Bull. 2008; 34: 354–366.
50
Glantz LA, Gilmore JH, Lieberman JA, Jarskog LF. Apoptotic mechanisms and the synaptic pathology of schizophrenia. Schizophr. Res. 2006; 81: 47–63.
51
Jarskog LF, Glantz LA, Gilmore JH, Lieberman JA. Apoptotic mechanisms in the pathophysiology of schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005; 29: 846–858.
52
Medina S, Martinez M, Hernanz A. Antioxidants inhibit the human cortical neuron apoptosis induced by hydrogen peroxide, tumor necrosis factor alpha, dopamine and beta-amyloid peptide 1-42. Free Radic. Res. 2002; 36: 1179–1184.
53
Buntinx M, Moreels M, Vandenabeele F et al. Cytokine-induced cell death in human oligodendroglial cell lines: I. Synergistic effects of IFN-gamma and TNF-alpha on apoptosis. J. Neurosci. Res. 2004; 76: 834–845.
Direct Link:
54
Palluy O, Rigaud M. Nitric oxide induces cultured cortical neuron apoptosis. Neurosci. Lett. 1996; 208: 1–4.
55
Hu S, Peterson PK, Chao CC. Cytokine-mediated neuronal apoptosis. Neurochem. Int. 1997; 30: 427–431.
56
Sunico CR, Portillo F, Gonzalez-Forero D, Moreno-Lopez B. Nitric-oxide-directed synaptic remodeling in the adult mammal CNS. J. Neurosci. 2005; 25: 1448–1458.
57
Stellwagen D, Malenka RC. Synaptic scaling mediated by glial TNF-alpha. Nature 2006; 440: 1054–1059.
58
Roberts RC, Roche JK, Conley RR. Synaptic differences in the postmortem striatum of subjects with schizophrenia: A stereological ultrastructural analysis. Synapse 2005; 56: 185–197.
Direct Link:
59
Price G, Cercignani M, Bagary MS et al. A volumetric MRI and magnetization transfer imaging follow-up study of patients with first-episode schizophrenia. Schizophr. Res. 2006; 87: 100–108.
60
Schlosser RG, Nenadic I, Wagner G et al. White matter abnormalities and brain activation in schizophrenia: A combined DTI and fMRI study. Schizophr. Res. 2007; 89: 1–11.
61
Uranova NA, Vostrikov VM, Orlovskaya DD, Rachmanova VI. Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: A study from the Stanley Neuropathology Consortium. Schizophr. Res. 2004; 67: 269–275.
62
Uranova NA, Vostrikov VM, Vikhreva OV, Zimina IS, Kolomeets NS, Orlovskaya DD. The role of oligodendrocyte pathology in schizophrenia. Int. J. Neuropsychopharmacol. 2007; 10: 537–545.
63
Iwamoto K, Ueda J, Bundo M, Nakano Y, Kato T. Effect of a functional single nucleotide polymorphism in the 2′,3′-cyclic nucleotide 3′-phosphodiesterase gene on the expression of oligodendrocyte-related genes in schizophrenia. Psychiatry Clin. Neurosci. 2008; 62: 103–108.
Direct Link:
64
McCullumsmith RE, Gupta D, Beneyto M et al. Expression of transcripts for myelination-related genes in the anterior cingulate cortex in schizophrenia. Schizophr. Res. 2007; 90: 15–27.
65
Li J, Baud O, Vartanian T, Volpe JJ, Rosenberg PA. Peroxynitrite generated by inducible nitric oxide synthase and NADPH oxidase mediates microglial toxicity to oligodendrocytes. Proc. Natl Acad. Sci. USA 2005; 102: 9936–9941.
66
Merrill JE, Ignarro LJ, Sherman MP, Melinek J, Lane TE. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 1993; 151: 2132–2141.
67
Cammer W, Zhang H. Maturation of oligodendrocytes is more sensitive to TNF alpha than is survival of precursors and immature oligodendrocytes. J. Neuroimmunol. 1999; 97: 37–42.
68
Feldhaus B, Dietzel ID, Heumann R, Berger R. Effects of interferon-gamma and tumor necrosis factor-alpha on survival and differentiation of oligodendrocyte progenitors. J. Soc. Gynecol. Invest. 2004; 11: 89–96.
69
Lieberman JA, Tollefson GD, Charles C et al. Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch. Gen. Psychiatry 2005; 62: 361–370.
70
Chakos MH, Schobel SA, Gu H et al. Duration of illness and treatment effects on hippocampal volume in male patients with schizophrenia. Br. J. Psychiatry 2005; 186: 26–31.
71
Massana G, Salgado-Pineda P, Junque C et al. Volume changes in gray matter in first-episode neuroleptic-naive schizophrenic patients treated with risperidone. J. Clin. Psychopharmacol. 2005; 25: 111–117.
72
Girgis RR, Diwadkar VA, Nutche JJ, Sweeney JA, Keshavan MS, Hardan AY. Risperidone in first-episode psychosis: A longitudinal, exploratory voxel-based morphometric study. Schizophr. Res. 2006; 82: 89–94.
73
Lu LX, Guo SQ, Chen W, Li Q, Cheng J, Guo JH. Effect of clozapine and risperidone on serum cytokine levels in patients with first-episode paranoid schizophrenia. Academic journal of the first medical college of PLA. Di Yi Jun Yi Da Xue Xue Bao 2004; 24: 1251–1254 (in Chinese).
- PubMed
74
Miyaoka T, Yasukawa R, Yasuda H, Hayashida M, Inagaki T, Horiguchi J. Possible antipsychotic effects of minocycline in patients with schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2007; 31: 304–307.
75
Miyaoka T, Yasukawa R, Yasuda H, Hayashida M, Inagaki T, Horiguchi J. Minocycline as adjunctive therapy for schizophrenia: An open-label study. Clin. Neuropharmacol. 2008; 31: 287–292.
76
Kowalski J, Labuzek K, Herman ZS. Flupentixol and trifluperidol reduce secretion of tumor necrosis factor-alpha and nitric oxide by rat microglial cells. Neurochem. Int. 2003; 43: 173–178.
77
Kowalski J, Labuzek K, Herman ZS. Flupentixol and trifluperidol reduce interleukin-1 beta and interleukin-2 release by rat mixed glial and microglial cell cultures. Pol. J. Pharmacol. 2004; 56: 563–570.
78
Labuzek K, Kowalski J, Gabryel B, Herman ZS. Chlorpromazine and loxapine reduce interleukin-1beta and interleukin-2 release by rat mixed glial and microglial cell cultures. Eur. Neuropsychopharmacol. 2005; 15: 23–30.
79
Hou Y, Wu CF, Yang JY et al. Effects of clozapine, olanzapine and haloperidol on nitric oxide production by lipopolysaccharide-activated N9 cells. Prog. Neuropsychopharmacol. Biol. Psychiatry 2006; 30: 1523–1528.
80
Kato T, Monji A, Hashioka S, Kanba S. Risperidone significantly inhibits interferon-gamma-induced microglial activation in vitro. Schizophr. Res. 2007; 92: 108–115.
81
Bian Q, Kato T, Monji A et al. The effect of atypical antipsychotics, perospirone, ziprasidone and quetiapine on microglial activation induced by interferon-gamma. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008; 32: 42–48.
82
Kato T, Mizoguchi Y, Monji A et al. Inhibitory effects of aripiprazole on interferon-gamma-induced microglial activation via intracellular Ca2+ regulation in vitro. J. Neurochem. 2008; 106: 815–825.
Direct Link:
83
Zheng LT, Hwang J, Ock J, Lee MG, Lee WH, Suk K. The antipsychotic spiperone attenuates inflammatory response in cultured microglia via the reduction of proinflammatory cytokine expression and nitric oxide production. J. Neurochem. 2008; 107: 1225–1235.
Direct Link:
84
Schwarz MJ, Muller N, Riedel M, Ackenheil M. The Th2-hypothesis of schizophrenia: A strategy to identify a subgroup of schizophrenia caused by immune mechanisms. Med. Hypotheses 2001; 56: 483–486.
85
Rothermundt M, Arolt V, Bayer TA. Review of immunological and immunopathological findings in schizophrenia. Brain Behav. Immun. 2001; 15: 319–339.
86
Cazzullo CL, Sacchetti E, Galluzzo A et al. Cytokine profiles in drug-naive schizophrenic patients. Schizophr. Res. 2001; 47: 293–298.
87
Pocock JM, Kettenmann H. Neurotransmitter receptors on microglia. Trends Neurosci. 2007; 30: 527–535.
88
Lu XH, Dwyer DS. Second-generation antipsychotic drugs, olanzapine, quetiapine, and clozapine enhance neurite outgrowth in PC12 cells via PI3K/AKT, ERK, and pertussis toxin-sensitive pathways. J. Mol. Neurosci. 2005; 27: 43–64.
89
Suzuki T, Hide I, Matsubara A et al. Microglial alpha7 nicotinic acetylcholine receptors drive a phospholipase C/IP3 pathway and modulate the cell activation toward a neuroprotective role. J. Neurosci. Res. 2006; 83: 1461–1470.
Direct Link:
90
Lieberman JA, Javitch JA, Moore H. Cholinergic agonists as novel treatments for schizophrenia: The promise of rational drug development for psychiatry. Am. J. Psychiatry 2008; 165: 931–936.
91
Raison CL, Capuron L, Miller AH. Cytokines sing the blues: Inflammation and the pathogenesis of depression. Trends Immunol. 2006; 27: 24–31.
92
Tyring S, Gottlieb A, Papp K et al. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: Double-blind placebo-controlled randomised phase III trial. Lancet 2006; 367: 29–35.
93
Knight JG, Menkes DB, Highton J, Adams DD. Rationale for a trial of immunosuppressive therapy in acute schizophrenia. Mol. Psychiatry 2007; 12: 424–431.

View Full Article (HTML) Get PDF (193K)

JOURNAL TOOLS

JOURNAL MENU

FIND ISSUES

FIND ARTICLES

GET ACCESS

FOR CONTRIBUTORS

ABOUT THIS JOURNAL

SPECIAL FEATURES

Cytokines and schizophrenia: Microglia hypothesis of schizophrenia

Psychiatry and Clinical Neurosciences

How to Cite

Author Information

Publication History

ARTICLE TOOLS

REFERENCES

More content like this

JOURNAL TOOLS

JOURNAL MENU

FIND ISSUES

FIND ARTICLES

GET ACCESS

FOR CONTRIBUTORS

ABOUT THIS JOURNAL

SPECIAL FEATURES

Cytokines and schizophrenia: Microglia hypothesis of schizophrenia

Psychiatry and Clinical Neurosciences

How to Cite

Author Information

Publication History

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

REFERENCES

More content like this